Treatment of Livedoid Vasculopathy With Baricitinib

JAMA Dermatol. 2022 May 1;158(5):587-589. doi: 10.1001/jamadermatol.2022.0241.

Authors

Xiaoting Song¹, Ping Tu¹

Affiliation

¹ Department of Dermatology and Venereology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.

PMID: 35353137
DOI: 10.1001/jamadermatol.2022.0241

No abstract available

MeSH terms

Azetidines* / therapeutic use
Humans
Livedo Reticularis* / therapy
Livedoid Vasculopathy*
Purines
Pyrazoles / therapeutic use
Sulfonamides

Substances

Azetidines
Purines
Pyrazoles
Sulfonamides
baricitinib